BioSpace News Archive

Policy

Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing

The U.S. Food and Drug Administration reissued an emergency use authorization to Quest Diagnostics to authorize its Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation.

July 18, 2020
·
3 min read
Business

American Osteopathic Association Installs Thomas Ely, DO, as 124th President

Combat veteran, lifelong leader and family medicine physician, Dr. Ely to prioritize support for members during COVID-19 crisis.

July 18, 2020
·
4 min read
Policy

Statement from the Chief Public Health Officer of Canada on July 18, 2020

In lieu of an in-person update to the media, Dr. Howard Njoo, Canada’s Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada’s Chief Public Health Officer.

July 18, 2020
·
2 min read
Policy

FDA Authorizes Quest Diagnostics COVID-19 Diagnostic Testing for Specimen Pooling for Emergency Use

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced that it has received emergency use authorization from the U.S. Food and Drug Administration to use specimen pooling with its proprietary molecular diagnostic test for COVID-19.

July 18, 2020
·
6 min read